Eton Pharmaceuticals (ETON) Work In Process (2024 - 2026)
Eton Pharmaceuticals (ETON) posted Work In Process of $9.4 million for Q4 2025, up 186.83% sequentially from $3.3 million in Q4 2024, and up 186.83% YoY from $3.3 million in Q4 2024.
Eton Pharmaceuticals (ETON) Work In Process (2024 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Work In Process for 2 years, with the latest figure at $9.4 million in Q4 2025.
- Quarterly Work In Process rose 186.83% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (up 186.83% YoY) and the FY2025 annual result came in at $9.4 million, up 186.83% from the prior year.
- Work In Process improved to $9.4 million in Q4 2025 per ETON's latest filing, from $3.3 million in the prior quarter.
- Over five years, Work In Process peaked at $9.4 million in Q4 2025 and troughed at $3.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Eton Pharmaceuticals | 1.68 Bn | 1.65 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Dec 31, 2025 | 9.43 Mn |
| Dec 31, 2024 | 3.29 Mn |